Turtle Cameron (CIK 1758363) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell SYRE (10,176 shares), Sell SYRE (4,234 shares), Sell SYRE (590 shares), Sell SYRE (3,557 shares), Sell SYRE (8,149 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 10,176 | $889,789 |
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 4,234 | $373,100 |
| 2026-07-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 590 | $52,457 |
| 2026-06-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 3,557 | $246,856 |
| 2026-06-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 8,149 | $574,504 |
| 2026-06-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 3,294 | $235,126 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 5,300 | $368,562 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 3,600 | $254,772 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 1,000 | $71,760 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 3,100 | $226,734 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 1,700 | $126,191 |
| 2026-05-01 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 300 | $22,488 |
| 2026-04-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 12,344 | $607,325 |
| 2026-04-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 2,656 | $132,588 |
| 2026-03-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 5,900 | $246,207 |
| 2026-03-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 9,100 | $386,659 |
| 2026-02-04 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 957 | $30,452 |
| 2026-02-04 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 14,043 | $461,593 |
| 2026-01-06 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 12,709 | $387,243 |
| 2026-01-06 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 2,191 | $69,652 |
| 2026-01-06 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 100 | $3,239 |
| 2025-12-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 10,995 | $315,886 |
| 2025-12-03 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 4,005 | $119,469 |
| 2025-11-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 28,155 | $651,225 |
| 2025-11-05 | Spyre Therapeutics, Inc. (SYRE) | Chief Executive Officer | Sell | 16,845 | $398,553 |
Source: SEC Form 4 filings · as of 2026-07-02